Trial Profile
Long-Term Compassionate Use Study for Continued Administration of SCB01A In Subjects Who Completed Treatment With SCB01A in the Previous Protocol SCB01A-01
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jul 2021
Price :
$35
*
At a glance
- Drugs SB 01 (Primary)
- Indications Cholangiocarcinoma; Colorectal cancer; Head and neck cancer; Laryngeal cancer; Lung cancer; Neuroendocrine carcinoma; Neuroendocrine tumours; Oesophageal cancer; Pancreatic cancer; Soft tissue sarcoma; Solid tumours; Thyroid cancer
- Focus Adverse reactions; Expanded access
- Sponsors SynCore Biotechnology
- 12 Nov 2020 Status changed from recruiting to completed.
- 17 Sep 2014 New trial record